National Institute of Mental Health (NIMH): Schizophrenia trials

The registry lists 35 Schizophrenia studies with National Institute of Mental Health (NIMH) as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 3Phase 2 5Phase 3 2Phase 4 6No phase 20(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study)CompletedNCT00816907Phase 4Results posted
• Comparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaCompletedNCT00802100Phase 4Results posted
• The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) GenotypeTerminatedNCT00548327Phase 2Results posted
• Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderCompletedNCT00423878Phase 4Results posted
• Clinical Trial of Tolcapone for Cognition in SchizophreniaTerminatedNCT00044083Phase 2Results posted
• Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic DisordersCompletedNCT00001656Phase 4Results posted
• Procedures for Sample Acquisition and Distribution for The Human Brain Collection CoreTerminatedNCT03092687
• Daily Intranasal Oxytocin for Childhood-Onset SchizophreniaTerminatedNCT01712646Phase 1/2
• Imaging Cannabinoid CB1 Receptors in SchizophreniaTerminatedNCT01063335
• Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission TomographyCompletedNCT00942981
• Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical NetworkCompletedNCT00930150Phase 4
• Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset SchizophreniaTerminatedNCT00757497Phase 1
• Usability of a Website for People With SchizophreniaWithdrawnNCT00177879Not applicable
• Imaging of Brain Receptors in Healthy Volunteers and in Patients With SchizophreniaCompletedNCT00061789Phase 2
• Effects of Modafinil on Brain Function in Patients With SchizophreniaCompletedNCT00057707Phase 1
• Screening for Childhood-Onset Psychotic DisordersTerminatedNCT00049738
• PET Scanning in Parkinson s DiseaseCompletedNCT00024622
• CATIE- Schizophrenia TrialCompletedNCT00014001Phase 4
• Glycine to Treat Psychotic Disorders in ChildrenCompletedNCT00005658Phase 2
• Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy VolunteersCompletedNCT00004571
• Electrophysiology and Blood Flow in Patients With Schizophrenia and Their SiblingsCompletedNCT00001921
• Eye Blink Response in Healthy Volunteers and Adults With SchizophreniaCompletedNCT00001920
• I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal VolunteersCompletedNCT00001771
• Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)CompletedNCT00001768Phase 3
• Genetic Aspects of Neurologic and Psychiatric DisordersCompletedNCT00001544
• Genetic Study of SchizophreniaCompletedNCT00001486
• Neuropsychiatric Evaluation of Healthy Volunteers and Adults With SchizophreniaCompletedNCT00001323
• Neuroimaging of Dopamine Metabolism in Normal and Psychiatric PatientsCompletedNCT00001320
• Brain Tissue Collection for Neuropathological StudiesTerminatedNCT00001260
• Studies of Frontal Lobe Brain Functioning in SchizophreniaCompletedNCT00001258
• Inpatient Evaluation of Adults With SchizophreniaCompletedNCT00001247
• Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy VolunteersCompletedNCT00001246
• Evaluating Genetic Risk Factors for Childhood-Onset SchizophreniaTerminatedNCT00001198
• Neuropsychological Evaluation of Psychiatric and Neurological PatientsCompletedNCT00001192
• Self-Management Therapy for Youth With SchizophreniaCompletedNCT00000387Phase 3